|
|
|
RGC Price Target
Recent RGC Price |
|
RGC Price Target |
$0.00 |
NA% |
$0.00 |
As of
Recent RGC Analyst Ratings Breakdown |
|
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
Strong buy ratings: |
|
|
|
|
Buy ratings: |
|
|
|
|
Hold ratings: |
|
|
|
|
Sell ratings: |
|
|
|
|
Strong sell ratings: |
|
|
|
|
Average rating: |
|
|
|
|
The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is
Strong Sell. For the RGC price target at the top of this page, we present the average RGC target price
across the analysts covering RGC, as reported in
data provided by Zacks Investment Research via Quandl.com. The
median RGC price target (a different metric than the average or mean) was $ as of , the
highest RGC price target in the range was $ while the lowest RGC price target in the range was
$, with a standard deviation of $. Get the latest Zacks research report on RGC — FREE
10 ETFs With Most Upside
To Analyst Targets
Top 25 Broker Analyst Picks of the
S&P 500
For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the
ETF as far as deciding whether to continue to hold the stock. ETFs by nature are passive index-followers, so as long as the
stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Below are some
of the ETFs that hold RGC at last report:
ETF |
RGC Weight |
RGC Amount |
DIV |
0.50% |
$988,394 |
|
Company Name: |
Regencell Bioscience Holdings Ltd |
Website: |
www.regencellbioscience.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding RGC: |
1 |
Total Market Value Held by ETFs: |
$988,394 |
Total Market Capitalization: |
$44,000,000 |
% of Market Cap. Held by ETFs: |
2.25% |
|
|
|
|
Hold (2.17 out of 4)
81st percentile
|
|
|